Select Committee on Science and Technology Appendices to the Minutes of Evidence


Memorandum submitted by the Roy Castle International Centre Lung Cancer Research

  I enclose a statement relating to the difficulties we are encountering in carrying out our research programme aimed at the identification of people at high risk of developing lung cancer and new methods of early detection of the disease. In the main, these problems have arisen in the wake of the implementation of the Caldicott Report, the Data protection act 1998 and the GMC Guidelines.

  We were fortunate recently to spend some time with Dr Liam O'Toole, Director of the National Cancer Research Institute when he visited the Roy Castle Centre for Lung Cancer Research and discussed the aims and objectives and future vision of the NCRI. He was very supportive of the early detection research being undertaken here and we look forward to being involved in future initiatives. We have strong collaboration with local clinicians but as yet little involvement with the Merseyside and Cheshire Cancer Network.

  We look forward to the development of a stronger collaborative research strategy between the NHS and academic institutions to enable partnerships and facilitate research programmes for the benefit of the health of our population. Such a collaborative strategy is urgently required to break down some of the barriers to for non-NHS organisations carrying out research within the NHS environment.

  We are all agreed that research into all aspects of cancer remains a pressing need and hope that the means to achieve our aims will become available in the near future.

Professor John Field

Director of Research

Dr Judith Youngson

Associate Director of Research

6 December 2001

previous page contents next page

House of Commons home page Parliament home page House of Lords home page search page enquiries index

© Parliamentary copyright 2002
Prepared 20 March 2002